Provided by Tiger Trade Technology Pte. Ltd.

Central Garden & Pet

37.35
+0.01000.03%
Post-market: 37.350.00000.00%18:02 EST
Volume:66.01K
Turnover:2.46M
Market Cap:2.33B
PE:15.09
High:37.82
Open:37.65
Low:36.88
Close:37.34
52wk High:41.25
52wk Low:28.77
Shares:62.33M
Float Shares:57.71M
Volume Ratio:0.70
T/O Rate:0.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.47
EPS(LYR):2.55
ROE:10.12%
ROA:4.57%
PB:1.48
PE(LYR):14.65

Loading ...

Central Garden & Pet Appoints Kay M. Schwichtenberg to Board of Directors

Reuters
·
10 hours ago

Central Garden & Pet Announces Kay M. Schwichtenberg as New Director

THOMSON REUTERS
·
10 hours ago

Director Brendan Dougher Reports Sale of Central Garden & Pet Company Common Shares

Reuters
·
Yesterday

U.S. RESEARCH ROUNDUP-Align Technology, Biogen, Citigroup

Reuters
·
Feb 09

Central Garden & Pet Co : JP Morgan Raises Target Price to $33 From $28

THOMSON REUTERS
·
Feb 09

Stock Track | Central Garden & Pet Soars 5.35% Intraday on Better-Than-Expected Q1 Earnings

Stock Track
·
Feb 06

Stock Track | Central Garden & Pet Plummets 5.27% Intraday After Revenue Miss and Cautious Outlook

Stock Track
·
Feb 05

Press Release: GLP China Holdings Limited TENDER OFFER TO PURCHASE FOR CASH ANY AND ALL OF ITS U.S.$700,000,000 2.95 PER CENT. NOTES DUE 2026

Dow Jones
·
Feb 05

Central Garden & Pet Q1 Adjusted EPS USD 0.21 Vs. IBES Estimate USD 0.14

Reuters
·
Feb 05

Central Garden & Pet Q1 Adj. EPS $0.21 Beats $0.14 Estimate, Sales $617.373M Miss $627.700M Estimate

Benzinga
·
Feb 05

Central Garden & Pet Co: 2026 Outlook Capital Expenditures Are Projected to Be Approximately $50 Million to $60 Million

THOMSON REUTERS
·
Feb 05

Central Garden & Pet Q1 Adjusted EPS USD 0.21 VS. Ibes Estimate USD 0.14

THOMSON REUTERS
·
Feb 05

Central Garden & Pet Co: Outlook Excludes Potential Impacts From Acquisitions, Divestitures, or Restructuring Activities That May Occur in 2026

THOMSON REUTERS
·
Feb 05

Central Garden & Pet Co Reaffirms Outlook for Fiscal 2026 Non-Gaap Diluted EPS of $2.70 or Better

THOMSON REUTERS
·
Feb 05

Central Garden & Pet Announces Q1 Fiscal 2026 Financial Results

THOMSON REUTERS
·
Feb 05

Nature Medicine Publishes Results from the Pivotal DEVOTE Study of High-Dose Regimen of Nusinersen in Spinal Muscular Atrophy

GlobeNewswire
·
Feb 04

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 04

Press Release: Central Garden & Pet to Announce Q1 Fiscal 2026 Financial Results

Dow Jones
·
Jan 27

Central Garden & Pet Appoints Apur Patel as Chief Legal Officer

Reuters
·
Jan 27

U.S. RESEARCH ROUNDUP-Autonation, Eastman Chemical, Fortive

Reuters
·
Jan 16